Literature DB >> 9233677

Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum.

J C Hafalla1, M L Santiago, M C Pasay, B L Ramirez, M M Gozar, A Saul, D C Kaslow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233677     DOI: 10.1016/s0166-6851(97)00042-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  6 in total

Review 1.  Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.

Authors:  Ajay K Saxena; Yimin Wu; David N Garboczi
Journal:  Eukaryot Cell       Date:  2007-06-08

2.  Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes.

Authors:  H Hisaeda; A W Stowers; T Tsuboi; W E Collins; J S Sattabongkot; N Suwanabun; M Torii; D C Kaslow
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

Authors:  T Tsuboi; D C Kaslow; M M Gozar; M Tachibana; Y M Cao; M Torii
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

Review 4.  Flipping the paradigm on malaria transmission-blocking vaccines.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Trends Parasitol       Date:  2008-07-01

5.  Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection.

Authors:  Takeshi Arakawa; Mayumi Tachibana; Takeshi Miyata; Tetsuya Harakuni; Hideyasu Kohama; Yasunobu Matsumoto; Naotoshi Tsuji; Hajime Hisaeda; Anthony Stowers; Motomi Torii; Takafumi Tsuboi
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

6.  Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates.

Authors:  Jack S Richards; Nicholas J MacDonald; Damon P Eisen
Journal:  Malar J       Date:  2006-07-05       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.